Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely ibandronic acid 50 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibandronic acid 1mg/mL intravenous infusion conc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ibandronic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ibandronic acid 1mg/mL injection solution 3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibandronic acid 1mg/mL injection solution 6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibandronic acid 1mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibandronic acid therapy |
Direct substance |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ibandronic acid 50 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronic acid 50 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronic acid 50 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ibandronate sodium (substance) |
Is modification of (attribute) |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ibandronic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ibandronic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ibandronic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ibandronic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ibandronic acid only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium) 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ibandronic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |